Nuclear pore complex interacting protein family member A9 (NPIPA9)

**NPIPA9** (Nuclear pore complex interacting protein family member A9) is a gene annotated in genomic databases (e.g., Ensembl, NCBI, GeneOntology)[3][5][2]. The gene belongs to a family with a nomenclature suggesting interaction with the nuclear pore complex, which is a multi-protein channel regulating transport between the nucleus and cytoplasm in eukaryotic cells[1]. There is no protein characterization, no functional annotation beyond generic family assignment, and no evidence for a defined role in any major biological process, disease, or as a drug target.\n\n**Key issues and gaps:**\n- There is no evidence this gene is a clinically validated or experimentally relevant drug target.\n- No functional studies, drug associations, or biomarker information are available.\n- The presence of terms such as "pseudogene" among its aliases indicates this may be a misannotation or non-functional remnant gene in some contexts.\n- Its molecular classification is unclear due to lack of protein function data; it is not known to be a receptor, enzyme, transporter, ion channel, or transcription factor but is likely classified as "Other" unless future characterization emerges.\n- There are no reported biological functions, mechanisms of action, interacting drugs, or safety concerns.\n\n**Conclusion:**\n**NPIPA9** does not match an established therapeutic target, and there appear to be significant gaps or inaccuracies in its current annotation, making it unsuitable for structured database entry regarding functional or therapeutic relevance[2][3][5].

Other names

Nuclear pore complex-interacting protein family member A9NPIPA9NPIP-like protein 1nuclear pore complex interacting protein family member A5 pseudogene